Profound Medical Corp.

NASDAQ: PROF · Real-Time Price · USD
5.22
-0.32 (-5.78%)
At close: Aug 14, 2025, 3:59 PM

Profound Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
10.68M 7.2M 6.68M 6.87M
Cost of Revenue
3.64M 2.82M 3.66M 3.92M
Gross Profit
7.04M 4.38M 3.02M 2.95M
Operating Income
-33.06M -28.62M -29.6M -30.29M
Interest Income
n/a 1.64M 1.05M 203.2K
Pretax Income
-26.48M -28.7M -28.38M -30.59M
Net Income
-26.48M -28.57M -28.67M -30.7M
Selling & General & Admin
23.13M 18.62M 17.93M 17.97M
Research & Development
16.96M 14.38M 14.69M 15.28M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
40.1M 33M 32.62M 33.24M
Interest Expense
n/a 932.8K 167.1K 66.41K
Selling & Marketing Expenses
n/a 9.45M 8.47M 7.65M
Cost & Expenses
43.74M 35.81M 36.28M 37.16M
Income Tax Expense
-2K -128K 287K 105K
Shares Outstanding (Basic)
24.77M 21.18M 20.83M 20.46M
Shares Outstanding (Diluted)
24.77M 21.18M 20.83M 20.47M
EPS (Basic)
-1.12 -1.35 -1.38 -1.5
EPS (Diluted)
-1.12 -1.35 -1.38 -1.5
EBITDA
-33.06M -26.78M -25.55M -28.65M
EBIT
-33.06M -27.93M -28.21M -30.53M
Depreciation & Amortization
n/a 1.15M 2.09M 2.36M